Class IIOngoingD-0910-2016
Drug recall · June 8, 2016
LGD-Xtreme recall
Why: Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL
- Lots / codes
Lot # 21511166, Exp 11/18
- Quantity
- 3,319 bottles
- Company
- Invisiblu International LLC, Fort Lauderdale, FL
- Distribution
- Nationwide and Brazil.
- Initiated
- March 31, 2016 · Voluntary: Firm initiated
- Classified
- May 27, 2016
- Reported
- June 8, 2016
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.